Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05373017 · ClinicalTrials.gov registry record · NA
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
A NA study of Delirium, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 528
- Enrollment target
- 6
- Study locations
NCT05373017: Recruiting NA study of Delirium, sponsored by University of Wisconsin, Madison.
NCT05373017 is a NA study of Delirium that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 528 participants, below the 879-participant average among 62 other Delirium trials with a reported enrollment target (40% lower). The trial reports 6 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05373017, a NA study of Delirium, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 528 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study will evaluate the usefulness of the Urgent and Emergency Surgery (UES) Delirium Recovery Model. It is hypothesized that the cognitive, physical and psychological recovery of older UES delirium survivors will be improved through the use of the DANE Recovery Model. Participants can expect to be on the study for 18 months.
Primary Outcome
Change in score on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) cognitive screening assessment. The measure consists of 12 subtests that contribute to a total score and Index scores across five domains: Immediate Memory, Visuospatial-Constructional, Language, Attention, and Delayed Memory. Index scores are converted to age-based standard scores (Mean = 100, Standard Deviation = 15)
Conditions Studied
Interventions
- OTHER Questionnaires
- OTHER DANE Recovery Program
Study Locations (6)
Wisconsin
- University of Wisconsin - Madison
- Meriter Hospital - Madison
- East Madison Hospital - Madison
- Medical College of Wisconsin - Milwaukee
Illinois
- SwedishAmerican Hospital - Rockford
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 528 participants |
| Start Date | 2023-02-13 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT05373017 shows while recruiting
NCT05373017 is an interventional study that assigns participants to a tested intervention. The registered 528 participants enrollment target is mid-sized for trials with a published cap, below the 879-participant average among 62 other Delirium trials with a reported enrollment target (40% lower).
The record links to 1 condition, with Delirium appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT05373017 lists 6 locations in 3 states (Wisconsin, Illinois, Indiana).
Frequently Asked Questions
What is clinical trial NCT05373017 about?
NCT05373017 is a clinical study titled "Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors". This study will evaluate the usefulness of the Urgent and Emergency Surgery (UES) Delirium Recovery Model. It is hypothesized that the cognitive, physical and psychological recovery of older UES delirium survivors will be improved through the use of the DANE Recovery Model. Participants can expect t...
What is the current status of trial NCT05373017?
This trial is currently recruiting. It is a NA study. The enrollment target is 528 participants. The study started on 2023-02-13. Estimated completion is 2027-06-30.
What conditions does trial NCT05373017 study?
This clinical trial studies the following conditions: Delirium.
What interventions are being tested in trial NCT05373017?
The interventions under investigation include: Questionnaires (OTHER), DANE Recovery Program (OTHER).
Who is sponsoring clinical trial NCT05373017?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05373017 being conducted?
This trial has 6 study locations across Illinois, Indiana, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delirium
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05373017's enrollment target sits among peer trials
528 14th of 62 higher than 49 of 62 other Delirium trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Delirium trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
RECRUITING · NA
-
VoiceLove Digital Therapy for Delirium in the ICU
RECRUITING · NA
-
TaVNS for Delirium
RECRUITING · NA
-
Neurosteer Bedside Monitoring System
RECRUITING · NA
-
Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
RECRUITING · NA
-
Modifying the Inpatient Environment to Reduce Delirium in Older Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05634252 · 528 participants · Phase 3
Undergraduate Skin Cancer Prevention Trial
- NCT06383273 · 528 participants · Phase 3
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
- NCT06470243 · 528 participants · Phase 3
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- NCT06961058 · 528 participants · NA
Telehealth vs In-Person Evaluation of Addiction Treatment After Visiting the Emergency Department
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI